  
|
|
 |  |  |  |  |  |  |
|
Lupus/Connective Tissue Diseases
|
|
|
SNOWMASS, COLO. - Low-dose methotrexate is highly effective for treatment of antimalarial-resistant discoid lupus or subacute cutaneous lupus erythematosus. "If you have to pick one thing past Plaquenil [hydroxychloroquine], I’d say try methotrexate," declared Dr. Ruth Ann... »
JSLE Imparts Severe Organ Involvement
Children with juvenile-onset systemic lupus erythematosus tend to have significant disease activity and high rates of organ involvement with damage accumulation, according to findings from the UK JSLE Cohort Study. The findings underscore the complex and severe nature of JSLE and the need for... »
Ondansetron Quells Methotrexate-Induced Nausea
LISBON – Getting an earful of complaints of nausea from your patients on oral methotrexate therapy? Consider bracketing the antifolate drug with the antiemetic ondansetron before and afterward, Dr. Richard B. Warren suggested at the congress. Dr. Richard B. Warren "One successful means of... »
SNOWMASS, COLO. - Low-dose methotrexate is highly effective for treatment of antimalarial-resistant discoid lupus or subacute cutaneous lupus erythematosus. "If you have to pick one thing past Plaquenil... »
Pegloticase Safe as Induction Therapy in Tophaceous Gout
SNOWMASS, COLO. – Many rheumatologists may have been scared off from using pegloticase in chronic refractory gout because of the much-publicized risk of infusion reactions – needlessly so, according to Dr. Robert L.... »
Obesity Epidemic Is Skewing Face of Gout
SNOWMASS, COLO. – The epidemiology of gout has changed considerably in the past several decades, rendering treatment more challenging. For example, today fully 21.4% of all U.S. adults are hyperuricemic as defined by a... »
CHICAGO – Women with low-activity systemic lupus erythematosus can have healthy pregnancies with few complications, even those with a history of renal disease. "The good news was that the overall pregnancy adverse... »
Methotrexate May Benefit Juvenile Scleroderma
Children with localized scleroderma responded better to methotrexate than to prednisone in a small, placebo-controlled trial, Dr. Francesco Zulian reports. View Video Now. »
| Feb 28 - Mar 4 Sarasota, FL | American Medical Seminars: Rheumatology |
| Mar 21 New York, NY | New York University (NYU): Pediatric Rheumatology |
| Mar 22 - 24 New York, NY | New York University/Hospital for Joint Disease: Seminar in Advanced Rheumatology |
| Mar 28 - 31 Victoria, | Canadian Rheumatology Association (CRA): Scientific Conference and Annual General Meeting |
| Apr 26 - 29 Barcelona, | OsteoArthritis Research Society International (OARSI): World Congress on Osteoarthritis |
| Apr 27 - 29 Chicago, IL | American College of Rheumatology (ACR): State-of-the-Art Clinical Symposium |
| Apr 27 - 28 Baltimore, MD | Johns Hopkins University (JHU): Advances in the Diagnosis and Treatment of the Rheumatic Diseases |
| Apr 27 - 29 Marina del Rey, CA | University of California, Los Angeles (UCLA): Carl M. Pearson Memorial Symposium: Frontiers of Rheumatology |
| May 1 - 4 Glasgow, | British Society for Rheumatology (BSR): Annual Conference (Rheumatology 2012) |
| May 2 - 6 Destin, FL | Congress of Clinical Rheumatology |